Literature DB >> 9269384

Ticlopidine induced cholestatic jaundice.

H B Yim1, P K Lieu, P W Choo.   

Abstract

Ticlopidine hydrochloride (Ticlid) has been increasingly used as an antiplatelet agent. Some studies showed that it has higher efficacy in reducing stroke recurrence when compared to conventional aspirin. Side effects like gastrointestinal disturbances and blood dyscrasias are common but ticlopidine-induced cholestatic jaundice has been reported only rarely. We present a case report on a patient who has ticlopidine-induced cholestatic jaundice.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9269384

Source DB:  PubMed          Journal:  Singapore Med J        ISSN： 0037-5675            Impact factor:   1.858


  2 in total

Review 1.  Ticlopidine-induced cholestatic hepatitis: report of three cases and review of the literature.

Authors:  M Iqbal; P Goenka; M F Young; E Thomas; T R Borthwick
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

2.  A new Poisson and Bayesian-based method to assign risk and causality in patients with suspected hepatic adverse drug reactions: a report of two new cases of ticlopidine-induced hepatotoxicity.

Authors:  Pedro Zapater; José Such; Miguel Pérez-Mateo; José Francisco Horga
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.